Inclusion Criteria:  Child / adolescent aged 8 to 16 years, diagnosed with ASD (DSM-5, ADOS, ADI-R criteria). Without intellectual delay (QNV> 70, WISC-IV or V, WAIS-III or IV). Benefiting from a treatment program at the University Center for Child Psychiatry (CHRU Bretonneau-Tours). Schooled in the ordinary school context (primary school, middle school, high school, ULIS).  Having expressed their agreement to participate in the study.  Whose parents or legal representatives have signed written consent. Whose parents or legal representatives are affiliated or beneficiaries of a social security scheme.  Exclusion Criteria:  Neuromotor disorders. Uncorrected visual disorders. Hearing impairment. Known epilepsy. Anxiety syndromes identified. Hyper ADD / H type activity. Treatment with methylphenidate. - Rare genetic syndrome.